Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 3M Company (MMM) vs Zoetis Inc (ZTS) Price & Performance

3M CompanyTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

3M Company vs Zoetis Inc — how do they compare? 3M Company trades at $160.39 (market cap $84.36B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: 3M Company is far larger — about 2.8× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold 3M Company for 169 Days and Zoetis Inc for 70 Days on average.

MMMZTS
Market Cap
$84.36B$30.20B
Volume
2,325,3016,175,327
Sector
IndustrialsHealth
52-Week High
$183.79$147.53
52-Week Low
$141.10$69.09
Typical Hold Time
169 Days70 Days
Enterprise Value
$93.58B$37.76B
Dividend Yield
1.91%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

3M Company

3M (MMM) trades at $159.96, down 1.33% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.40 versus $2.25 expected, and maintains a robust net income margin of 11.9%. Recent news highlights operational momentum, including raised guidance and progress on litigation management. Cash flow from operations improved to $2.31 billion in 2025, though net cash flow was negative $319 million due to financing activities.

The outlook is mixed; analyst consensus is a Buy with a $191 price target, implying 19% upside, but technical indicators suggest near-term pressure. Key risks include high debt levels, weak consumer segment demand, and cost pressures. Earnings growth and margin expansion remain critical for sustained stock appreciation amid competitive and macroeconomic challenges.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 3M Company

3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.

Read more on MMM →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →